NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

GCTK

GlucoTrack Inc

Apr 04 • 12:08PM ET

0.1657

Dollar change -0.0213
Percentage change -11.39	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DXCM ABT PODD TNDM LCTX MDT SENS OSUR LOCL BBSI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-68.06	Insider Own	2.34%	Shs Outstand	10.41M	Perf Week	-19.17%
Market Cap	4.24M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	10.17M	Perf Month	-50.54%
Income	-22.60M	PEG	-	EPS next Q	-	Inst Own	0.44%	Short Float	2.79%	Perf Quarter	-97.39%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	494.12%	Short Ratio	0.04	Perf Half Y	-99.63%
Book/sh	-16.42	P/B	-	EPS next Y	-	ROA	-417.03%	Short Interest	0.28M	Perf Year	-99.58%
Cash/sh	0.22	P/C	0.75	EPS next 5Y	-	ROE	-1943.32%	52W Range	0.16 - 99.00	Perf YTD	-97.78%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-18.33%	ROI	-	52W High	-99.83%	Beta	-0.18
Dividend TTM	-	Quick Ratio	4.52	Sales past 5Y	-20.00%	Gross Margin	-	52W Low	0.98%	ATR (14)	0.09
Dividend Ex-Date	-	Current Ratio	4.52	EPS Y/Y TTM	-94.61%	Oper. Margin	-	RSI (14)	27.71	Volatility	18.51% 22.45%
Employees	11	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-88.40%	Payout	-	Rel Volume	0.48	Prev Close	0.19
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	6.57M	Price	0.17
SMA20	-42.85%	SMA50	-70.13%	SMA200	-99.24%	Trades		Volume	1,365,255	Change	-11.39%

Apr-03-25 08:01AM	Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor (GlobeNewswire) -6.59%
Mar-31-25 05:00PM	Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights (GlobeNewswire) -14.88% +28.94%
Mar-19-25 08:01AM	Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes (GlobeNewswire) +8.90%
Feb-26-25 08:01AM	Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member (GlobeNewswire) +5.23%
Feb-05-25 11:52AM	Glucotrack Prices $3 Million Public Offering to Fund Expansion (GuruFocus.com) -12.47%
01:44PM	Loading…
Feb-04-25 01:44PM	Glucotrack hits trial success for direct blood measuring CGM (Medical Device Network) -28.95%
12:24PM	Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering (GlobeNewswire)
08:01AM	Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor (GlobeNewswire)
Jan-30-25 08:00AM	Glucotrack Announces Reverse Stock Split (GlobeNewswire) -24.06%
Jan-29-25 09:00AM	Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer (GlobeNewswire)
Jan-21-25 08:01AM	Glucotrack Announces ISO 13485:2016 Certification (GlobeNewswire) +47.23%
Jan-15-25 08:01AM	Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs (GlobeNewswire) -35.25%
Jan-07-25 04:05PM	Glucotrack to Present at TechBio Showcase 2025 (GlobeNewswire) -10.45%
Dec-03-24 08:30AM	GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
Nov-14-24 04:30PM	Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt (GlobeNewswire) -14.33% -12.06%
09:00AM	Loading…
Nov-13-24 09:00AM	Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering (GlobeNewswire) -77.06%
Oct-22-24 09:00AM	GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE (GlobeNewswire)
Oct-01-24 09:00AM	GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING (GlobeNewswire)
Sep-03-24 09:00AM	JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS (GlobeNewswire)
Aug-27-24 09:00AM	GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS (GlobeNewswire)
Aug-15-24 09:00AM	Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference (GlobeNewswire) +22.74%
Aug-05-24 09:00AM	GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE (GlobeNewswire)
Jul-31-24 04:00PM	GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) -6.25% +10.00%
Jun-20-24 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS (GlobeNewswire)
Jun-13-24 09:19AM	GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR (GlobeNewswire)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE) -7.19%
Jun-10-24 10:50AM	GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE (GlobeNewswire)
Jun-05-24 08:30AM	GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire)
May-17-24 02:52PM	GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 (InvestorPlace)
May-16-24 08:30AM	GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY (GlobeNewswire)
04:15PM	Loading…
May-15-24 04:15PM	GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT (GlobeNewswire) -10.20%
May-02-24 09:00AM	GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION (GlobeNewswire)
Apr-29-24 07:33AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) +23.00%
Apr-25-24 02:18AM	Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK) (GuruFocus.com)
Apr-22-24 02:10PM	GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT (GlobeNewswire) +9.88%
Apr-16-24 08:30AM	GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING (GlobeNewswire) +24.93%
Apr-03-24 07:00AM	Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now (GlobeNewswire) +13.33%
Apr-02-24 08:30AM	GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +7.46%
07:00AM	Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now (GlobeNewswire)
Mar-12-24 09:30AM	GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY (GlobeNewswire)
Feb-27-24 08:30AM	GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR (GlobeNewswire) +13.78%
Feb-13-24 09:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAV TO CHAIR OF THE BOARD OF DIRECTORS (GlobeNewswire) -10.79%
Feb-07-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now (GlobeNewswire) +6.28%
Feb-06-24 07:00AM	Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now (GlobeNewswire)
Jan-10-24 07:00AM	Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream (GlobeNewswire)
Jan-09-24 07:00AM	Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now (GlobeNewswire)
Jan-02-24 12:33PM	GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) +8.95%
Nov-30-23 05:39PM	GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT (GlobeNewswire) +7.31% +23.40%
Nov-13-23 09:00AM	GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE (GlobeNewswire)
Oct-12-23 08:30AM	GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire) -20.65%
Aug-31-23 08:30AM	GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS (GlobeNewswire)
Aug-28-23 09:00AM	GLUCOTRACK ANNOUNCES NEW VP OF MARKETING (GlobeNewswire)
Jul-26-23 02:30PM	The Power Play by The Market Herald Releases New Interviews with GlucoTrack and Acceleware Discussing Their Latest News (ACCESSWIRE) -7.95%
Jul-25-23 09:00AM	GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR (GlobeNewswire)
Apr-17-23 11:05AM	Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK) (ACCESSWIRE) -7.39%
09:15AM	GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Apr-13-23 09:22AM	GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock (GlobeNewswire) -49.26%
Apr-12-23 05:50PM	GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock (GlobeNewswire) +37.76%
Mar-14-23 10:00AM	GLUCOTRACK PROVIDES SHAREHOLDER UPDATE (GlobeNewswire) +16.94%

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SYCOFF DREW	Director	Apr 22 '24	Buy	1.26	182,540	230,000	2,951,258	Apr 24 06:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GCTK

GlucoTrack Inc

Upgrade your FINVIZ experience